Climb Bio, Inc. · NASDAQ:CLYM
Climb Bio, Inc. shareholders
As of Jun 30, 2026, 105 institutions reported holding Climb Bio, Inc., 98.1% of its shares. Largest: Ra Capital Management, L.P., Fidelity and UBS. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Climb Bio, Inc. | Change | Filed |
|---|---|---|---|---|
| Ra Capital Management, L.P. | 11.3M | 19.7% | no change | Aug 14, 2026 |
| Fidelity | 6.79M | 11.8% | +6.78M | Aug 13, 2026 |
| UBS | 3.4M | 5.9% | +3.32M | Aug 13, 2026 |
| Braidwell LP | 2.8M | 4.9% | +1.27M | Aug 14, 2026 |
| Adage Capital Partners Gp, L.L.C. | 2.51M | 4.4% | new | Aug 14, 2026 |
| BlackRock | 2.35M | 4.1% | +1.95M | Aug 7, 2026 |
| Vanguard | 2.14M | 3.7% | +796K | Aug 13, 2026 |
| T. Rowe Price | 2.13M | 3.7% | +210K | Aug 14, 2026 |
| Cormorant Asset Management, LP | 2.11M | 3.7% | new | Aug 14, 2026 |
| Frontier Capital Management Co LLC | 1.94M | 3.4% | new | Aug 14, 2026 |